Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation

American Journal of Pathology

Volumn 155, Issue 3, 1999, Pages 703-710

  Van Nhieu, Jeanne Tran ^a   Renard, Claire Angélique ^b   Wei, Yu ^b   Cherqui, Daniel ^a   Zafrani, Elie Serge ^a   Buendia, Marie Annick ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; SOMATIC MUTATION; TUMOR GROWTH;

EID: 0032885751     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9440(10)65168-1     Document Type: Article

References (33)

1. Murray CJL, Lopez AD: Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997, 349:1269-1276
2. Nagai H, Buendia MA: Oncogenes, tumor suppressors, and co-factors in hepatocellular carcinoma. Hepatitis B Virus. Edited by Koshy R, Caselman W, London, Imperial College Press, 1998, pp 182-218
3. Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A: Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997, 14:2927-2933
4. Murakami Y, Hayashi K, Hirohashi S, Sekiya T: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991, 51:5520-5525
5. Hsu HC, Peng SY, Lai PL, Sheu JC, Chen DS, Lin LI, Slagle BL, Butel JS: Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. Cancer 1994, 73:42-47
6. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL: M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 1995, 11:447-449
7. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M, Ishizaki K: Amplification and overexpression of the cyclin D1 gene in aggressive hepatocellular carcinoma. Cancer Res 1994, 54:3107-3110
8. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C: Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998, 95:8847-8851
9. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, Shimano T, Nakamura Y: Activation of the β-catenin gene in primary hepatocellular carcinoma by somatic alterations involving exon 3. Cancer Res 1998, 58:2524-2527
10. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-myc as a target of the APC pathway. Science 1998, 281:1509-1512
11. Tetsu O, McCormick F: β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426
12. Aberle H, Schwartz H, Kemler R: Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem 1996, 61:514-523
13. Cadigan KM, Nusse R: Wnt signaling: a common theme in animal development. Genes Dev 1997, 11:3286-3305
14. Polakis P: The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1997, 1332:F127-147
15. Clevers H, van de Wetering M: TCF/LEF factors earn their wings. Trends Genet 1997, 13:485-489
16. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ: WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 1998, 95:14717-14722
17. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997, 275:1787-1790
18. Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, Ishiguro S, Nakamura Y, Miyoshi Y: Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 1998, 58:1021-1026
19. Polakis P: The oncogenic activation of β-catenin. Curr Opin Genet Dev 1999, 9:15-21
20. Inomata M, Ochiai A, Akimoto S, Kitano S, Hirohashi S: Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res 1996, 56:2213-2217
21. Palacios J, Gamallo C: Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 1998, 58:1344-1347
22. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S, Hirohashi S: Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 1998, 58:3526-3528
23. Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER: Frequent nuclear/ cytoplasmic localization of β-catenin without exon 3 mutations in malignant melanoma. Am J Pathol 1999, 154:325-329
24. Pileri S, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E, Ascani S, Santini D, Piccaluga P, Leone O, Damiani S, Ercolessi C, Sandri F, Pieri F, Leoncini L, Falini B: Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol 1997, 183:116-123
25. Barnes D, Gillett C: Determination of cell proliferation. J Clin Pathol Clin Mol Pathol 1995, 48:M2-M5
26. Ishak K, Anthony P, Sobin L: Histological Typing of Tumors of the Liver. Berlin, Springer Verlag, 1994
27. Ihara A, Koizumi H, Hashizume R, Uchikoshi T: Expression of epithelial cadherin and α- and β-catenins in nontumoral livers and hepatocellular carcinoma. Hepatology 1996, 23:1441-1447
28. Voeller HJ, Truica CI, Gelmann EP: Beta-catenin mutations in human prostate cancer. Cancer Res 1998, 58:2520-2523
29. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P: Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 1996, 272:1023-1026
30. Ding SF, Delhanty JD, Dooley JS, Bowles L, Wood CB, Habib NA: The putative tumor suppressor gene on chromosome 5q for hepatocellular carcinoma is distinct from the MCC and APC genes. Cancer Detect Prev 1993, 17:405-409
31. Tanaka S, Akiyoshi T, Mori M, Wands J, Sugimachi K: A novel frizzled gene identified in human esophageal carcinoma mediates APC/β-catenin signals. Proc Natl Acad Sci USA 1998. 95:10164-10169
32. Kitamoto M, Nakanishi T, Kira S, Kawaguchi M, Nakashio R, Suemori S, Kajiyama G, Asahara T, Dohi K: The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis. Cancer 1993. 72:1859-1865
33. Tannapfel A, Geissler F, Köckerling F, Katalinic A, Hauss J, Wittekind C: Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma. J Pathol 1999, 187:439-445